Journey Medical Statistics
Total Valuation
Journey Medical has a market cap or net worth of $164.11 million. The enterprise value is $162.35 million.
Important Dates
The last earnings date was Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Journey Medical has 27.53 million shares outstanding. The number of shares has increased by 21.41% in one year.
| Current Share Class | 21.53M |
| Shares Outstanding | 27.53M |
| Shares Change (YoY) | +21.41% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 12.15% |
| Owned by Institutions (%) | 46.36% |
| Float | 14.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 40.41 |
| PS Ratio | 2.54 |
| Forward PS | 1.74 |
| PB Ratio | 5.28 |
| P/TBV Ratio | 37.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.83.
| Current Ratio | 1.72 |
| Quick Ratio | 1.38 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.71 |
Financial Efficiency
Return on equity (ROE) is -36.61% and return on invested capital (ROIC) is -20.37%.
| Return on Equity (ROE) | -36.61% |
| Return on Assets (ROA) | -4.49% |
| Return on Invested Capital (ROIC) | -20.37% |
| Return on Capital Employed (ROCE) | -11.81% |
| Weighted Average Cost of Capital (WACC) | 10.15% |
| Revenue Per Employee | $1.12M |
| Profits Per Employee | -$165,310 |
| Employee Count | 58 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 2.05 |
Taxes
In the past 12 months, Journey Medical has paid $60,000 in taxes.
| Income Tax | 60,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.09% in the last 52 weeks. The beta is 1.04, so Journey Medical's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -12.09% |
| 50-Day Moving Average | 5.58 |
| 200-Day Moving Average | 7.24 |
| Relative Strength Index (RSI) | 57.09 |
| Average Volume (20 Days) | 270,581 |
Short Selling Information
The latest short interest is 3.67 million, so 13.34% of the outstanding shares have been sold short.
| Short Interest | 3.67M |
| Short Previous Month | 3.72M |
| Short % of Shares Out | 13.34% |
| Short % of Float | 24.78% |
| Short Ratio (days to cover) | 17.57 |
Income Statement
In the last 12 months, Journey Medical had revenue of $64.68 million and -$9.59 million in losses. Loss per share was -$0.37.
| Revenue | 64.68M |
| Gross Profit | 42.33M |
| Operating Income | -6.34M |
| Pretax Income | -9.53M |
| Net Income | -9.59M |
| EBITDA | -2.02M |
| EBIT | -6.34M |
| Loss Per Share | -$0.37 |
Full Income StatementBalance Sheet
The company has $27.22 million in cash and $25.47 million in debt, with a net cash position of $1.75 million or $0.06 per share.
| Cash & Cash Equivalents | 27.22M |
| Total Debt | 25.47M |
| Net Cash | 1.75M |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | 30.83M |
| Book Value Per Share | 1.13 |
| Working Capital | 27.14M |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.70M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 4.32M |
| Net Borrowing | n/a |
| Free Cash Flow | -6.70M |
| FCF Per Share | -$0.24 |
Full Cash Flow StatementMargins
Gross margin is 65.44%, with operating and profit margins of -9.80% and -14.82%.
| Gross Margin | 65.44% |
| Operating Margin | -9.80% |
| Pretax Margin | -14.73% |
| Profit Margin | -14.82% |
| EBITDA Margin | -3.12% |
| EBIT Margin | -9.80% |
| FCF Margin | n/a |
Dividends & Yields
Journey Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.41% |
| Shareholder Yield | -21.41% |
| Earnings Yield | -5.84% |
| FCF Yield | -4.08% |
Analyst Forecast
The average price target for Journey Medical is $13.50, which is 126.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.50 |
| Price Target Difference | 126.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Journey Medical has an Altman Z-Score of 1.17 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.17 |
| Piotroski F-Score | 4 |
